Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 7/20 | 0.75 |
| ▸ | KDR | P35968 | 8/20 | 0.57 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.52 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.50 |
| ▸ | EPHB4 | P54760 | 2/20 | 0.49 |
| ▸ | TEK | Q02763 | 1/20 | 0.49 |
| ▸ | BRAF | P15056 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13459579 | 0.84 | RIPK1 (0.79) | RIPK1KDRTRPV1PDGFRB | |
| SCHEMBL13459593 | 0.80 | RET (0.64) | RIPK1KDRPDGFRBTEKBRAF | |
| SCHEMBL13459592 | 0.80 | RIPK1 (0.69) | RIPK1KDRTRPV1PDGFRBEPHB4 | |
| SCHEMBL13459936 | 0.77 | FLT1 (0.51) | RIPK1KDRTEKBRAF | |
| SCHEMBL13459937 | 0.77 | RIPK1 (0.48) | RIPK1KDR | |
| SCHEMBL5105289 | 0.76 | KDR (0.55) | RIPK1KDRPDGFRBEPHB4TEK | |
| SCHEMBL4554203 | 0.74 | KDR (0.76) | KDRTRPV1PDGFRB | |
| SCHEMBL4555004 | 0.74 | KDR (0.70) | KDRTRPV1 | |
| SCHEMBL19677976 | 0.73 | KDR (0.88) | KDRTRPV1 | |
| SCHEMBL118026 | 0.73 | KDR (1.00) | KDRTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010032986-A2 | NOVEL 5-(4-AMINOPHENYL)-ISOQUINOLINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PRODUCTION METHOD FOR SAME, AND COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PROPHYLAXIS AND TREATMENT OF MEDICAL CONDITION INDUCED BY RAF KINASE HYPERACTIVITY | 주식회사 이큐스팜 (KR) | 2010-03-25 | — | — | WO | disclosed |